Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Nautilus Biotechnology, Inc./ EFFECT

SEC Filing · EFFECT

Nautilus Biotechnology, Inc.

NAUTNASDAQEQUITYCurrent

SEC Filing

Filed Sep 18, 2026Accepted Sep 21, 2026, 12:15 AM EDTCIK 1808805Accession 9999999995-26-003012
View company →Permanent SEC source ↗
Share

Company context

Current securities

NAUTNASDAQ · EQUITY · Current
Historical securities (1)
ARYANASDAQ · EQUITY · Historical · closed Jun 9, 2021

Recent company filings

  1. 424B5 filingSep 18, 2026
  2. SCHEDULE 13D/A filingSep 11, 2026
  3. Entry into a Material Definitive Agreement · Termination of a Material Definitive AgreementSep 11, 2026
  4. S-3 filingSep 11, 2026
  5. SCHEDULE 13D/A filingAug 28, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗